Organic compounds
OwnerDaniel Umbricht, Baltazar Gomez-Mancilla +2inventors
InventorsDaniel Umbricht, Baltazar Gomez-Mancilla, Fabrizio Gasparini, Therese Di Paolo
Life of this patent
Estimating the term…
Abstract
The invention concerns the use an mGluR modulator, e.g. an mGluR5 modulator, for the treatment, prevention or delay of progression of Parkinson's Disease and associated disorders
Claims24
A method for the treatment, prevention or delay of progression of a disorder associated with Parkinson's Disease in a subject in need of such treatment, which comprises administering to said subject a therapeutically effective amount of an mGluR5 modulator.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A kit comprising an mGluR5 modulator and instructions for using the modulator in the treatment, prevention or delay of progression of a disorder associated with Parkinson's Disease.
A product comprising an mGluR modulator and levodopa (L-dopa) as a combined preparation for simultaneous, separate or sequential use in therapy.
Dependencies are inferred from the claim text.